Breaking News Instant updates and real-time market news.

LVS

Las Vegas Sands

$57.73

-0.36 (-0.62%)

, MGM

MGM Resorts

$25.75

-0.31 (-1.19%)

08:39
10/17/16
10/17
08:39
10/17/16
08:39

Chinese authorities detain several Crown Resorts employees, WSJ reports

Chinese authorities confirmed they have detained several employees of Crown Resorts, one of Australia's biggest casino operators, and the company's stock tumbled almost 15% and dragged down stocks of Macau-based casinos listed on the Hong Kong market, reported The Wall Street Journal. Melco Crown Entertainment (MPEL) is a 27% shareholder in Crown Resorts, the report noted. 18 Crown employees, including the head of the company's international VIP team, were detained as part of an investigation into gambling-related activities, the report noted. Other U.S.-listed companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM) and Wynn Resorts (WYNN). Reference Link

LVS

Las Vegas Sands

$57.73

-0.36 (-0.62%)

MGM

MGM Resorts

$25.75

-0.31 (-1.19%)

MPEL

Melco Crown

$15.52

-0.24 (-1.52%)

WYNN

Wynn Resorts

$93.37

-1.58 (-1.66%)

LVS Las Vegas Sands
$57.73

-0.36 (-0.62%)

09/14/16
ARGS
09/14/16
UPGRADE
ARGS
Buy
Las Vegas Sands upgraded on Macau outlook at Argus
As noted earlier, Argus upgraded Las Vegas Sands to Buy from Hold. Analyst John Staszak notes that Macau gross gaming revenue increased year-over-year last month for the first time in over two years. He says that Macau gambling is shifting towards the non-VIP market, where he believes that Las Vegas Sands is well-positioned. Target $67.
09/14/16
09/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Macy's (M) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying an attractive free cash flow and dividend yield makes the risk/reward attractive at current levels. 2. Fifth Third (FITB) upgraded to Buy from Neutral at Compass Point. 3. F5 Networks (FFIV) upgraded to Outperform from Perform at Oppenheimer with analyst Ittai Kidron saying the company has several potential drivers that could drive year-over-year product revenue growth back into positive territory in fiscal 2017. 4. Las Vegas Sands (LVS) upgraded to Buy from Hold at Argus with analyst John Staszak saying that Macau gambling is shifting towards the non-VIP market, where he believes that Las Vegas Sands is well-positioned. 5. DeVry (DV) upgraded to Outperform from Market Perform at Barrington with analyst Alexander Paris saying management's near-term goal is stabilizing revenue at DeVry University growing enrollment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
BOFA
10/04/16
UPGRADE
BOFA
Buy
Las Vegas Sands upgraded to Buy from Neutral at BofA/Merrill
10/04/16
BOFA
10/04/16
UPGRADE
Target $63
BOFA
Buy
Las Vegas Sands upgraded on expected estimate revisions at BofA/Merrill
BofA/Merrill analyst Shaun Kelley upgraded Las Vegas Sands to Buy and raised its price target to $63 from $52. The analyst said shares remain fairly under-owned and thinks estimate revisions will move higher due to market momentum, better ROI for Parisian, Cotai infrastructure additions, and optionality from Japan and real estate.
MGM MGM Resorts
$25.75

-0.31 (-1.19%)

09/28/16
DBAB
09/28/16
NO CHANGE
Target $29
DBAB
Buy
MGM Resorts near-term setup is attractive, says Deutsche Bank
After meeting with management, Deutsche Bank analyst Carlo Santarelli says MGM Resorts' valuation is compelling and the near-term setup is attractive. The company continues to execute on its growth strategies amid solid underlying demand in Las Vegas, Santarelli tells investors in a research note. He keeps a Buy rating on MGM with a $29 price target.
10/05/16
NOMU
10/05/16
NO CHANGE
Target $32
NOMU
Buy
MGM Resorts price target raised to $32 from $28 at Nomura
Nomura analyst Harry Curtis raised MGM Resorts' price target to 32 from $28 to reflect continued pricing upside in Las Vegas, the December opening of National Harbour, Q1 RevPAR growth in Las Vegas, and the Q2 opening of MGM Cotai. Curtis rates MGM Resorts a Buy.
10/06/16
ARGS
10/06/16
UPGRADE
ARGS
Buy
MGM Resorts upgraded to Buy from Hold at Argus
10/06/16
ARGS
10/06/16
UPGRADE
ARGS
Buy
MGM Resorts upgraded on positive outlook at Argus
As noted earlier, Argus upgraded MGM to Buy from Hold. Analyst John Staszak upgraded the stock based on what he sees as "prospects for solid growth in Las Vegas and early signs of recovery in Macau." The analyst believes that investors have not yet "fully recognized" the upbeat signs in Macau, and he thinks that the region will rebound in Q4 and 2017, sparked by the opening of new casinos there. Target $32.
MPEL Melco Crown
$15.52

-0.24 (-1.52%)

07/05/16
BERN
07/05/16
NO CHANGE
BERN
Macau casinos could benefit from Philippines ban, says Bernstein
After the president of the Philippines called for a ban of online gambling, Bernstein says that Macau casinos could benefit from such a ban. The firm notes that online Filipino gambling sites have targeted Chinese gamblers. Bernstein adds that "there have been concerns" that bad debt from VIP junket operators could undermine Macau casinos' balance sheet. However, Bernstein says that it sees no evidence of such a trend, and it remains upbeat o nthe casinos' long-term outlook.Publicly traded Macau casinos include Las Vegas Sands (LVS), Melco Crown (MPEL),MGM Resorts (MGM), and Wynn Resorts (WYNN).
07/19/16
HSBC
07/19/16
UPGRADE
HSBC
Buy
Melco Crown upgraded to Buy from Hold at HSBC
HSBC analysts led by Charlene Liu upgraded Melco Crown to Buy and said suboptimal performance of Studio City is in the price and its gradual ramp-up could lead to higher valuation over time. Liu lowered Melco Crown's price target to $15.50 from $16.60.
09/08/16
MACQ
09/08/16
INITIATION
Target $18.8
MACQ
Outperform
Melco Crown initiated with an Outperform at Macquarie
Macquarie analyst Zibo Chen initiated Melco Crown with an Outperform and $18.80 price target. The analyst is optimistic that Studio City will gradually ramp up by 4Q 2017 thanks to the company's non-gaming franchise; and increased traffic generated by nearby new projects such as the Parisian.
09/09/16
DBAB
09/09/16
UPGRADE
Target $17
DBAB
Buy
Melco Crown upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Karen Tang upgraded Melco Crown to Buy saying recent interviews with casino staff members indicate that Macau is at the start of a "mass-led GGR recovery." Both base mass and premium mass are growing again, Tang tells investors in a research note. The analyst raised her price target for the shares to $17 from $14.
WYNN Wynn Resorts
$93.37

-1.58 (-1.66%)

07/29/16
LYON
07/29/16
DOWNGRADE
LYON
Underperform
CLSA cuts Wynn Resorts to Underperform, says cannibalization risk underestimated
As previously reported, CLSA analyst Jon Oh downgraded Wynn Resorts to Underperform from Outperform. Along with its Q2 call, the company revealed that it expects to receive only 100 new tables for the Wynn Palace opening and expects to move a greater-than-expected 250 tables from Wynn Macau to Wynn Palace. While Oh does not think Wynn Palace's economics change in this scenario, he remains concerned that the market is underestimating the risk of self-cannibalization and a slower Macau EBITDA uplift. Oh keeps a $97 price target on the stock but believes the risk/reward ratio has become unfavorable following the stock's year-to-date rally of over 50%.
07/29/16
07/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GrubHub (GRUB) downgraded to Neutral from Buy at BofA/Merrill, to Neutral from Buy at Monness Crespi, and to Hold from Buy at Maxim. 2. Ford (F) downgraded to Neutral from Buy at Goldman with analyst Patrick Archambault saying share outperformance over the next 6-12 months will be difficult following the carmaker's weaker than expected second quarter results and profit warning for 2016. 3. Starz (STRZA) downgraded to Hold from Buy at Pivotal Research with analyst Jeffrey Wlodarczak saying the Starz/Lionsgate (LGF) pro-forma entity is fairly valued. 4. Western Digital (WDC) downgraded to Hold from Buy at Cross Research with the firm saying the company is either unwilling or unable to provide a reasonable level of precision to the newly combined businesses with SanDisk and the higher than expected cost structure, combined with compensation increases will be a drag. 5. Wynn Resorts (WYNN) downgraded to Reduce from Neutral at Nomura and to Underperform from Outperform at CLSA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/12/16
UGAM
08/12/16
DOWNGRADE
UGAM
Hold
Wynn Resorts downgraded to Hold from Buy at Union Gaming
08/12/16
08/12/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Macy's (M) downgraded to Neutral from Outperform at Macquarie with analyst Laurent Vasilescu saying the closure of 100 stores will have a greater impact than the $1B in 2017 sales projected by the company, and could be as much as $1.5B-$2B. 2. Wynn Resorts (WYNN) downgraded to Hold from Buy at Union Gaming. 3. Foot Locker (FL) downgraded to Mixed from Positive at OTR Global with the firm citing store manager checks that indicate product mix is pressuring sale growth. 4. Qualcomm (QCOM) downgraded to Neutral from Positive at Arete. 5. Barracuda (CUDA) downgraded to Underperform from Neutral at DA Davidson with analyst Mark Kelleher citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CTIX

Cellceutix

$1.14

-0.045 (-3.80%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Hot Stocks
Cellceutix Phase 2 trial dose escalates in second cohort for Brilacidin »

Cellceutix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$55.99

0.97 (1.76%)

, SFTBF

SoftBank

$62.00

1.93 (3.21%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Recommendations
T-Mobile, SoftBank, Sprint, DISH, AT&T, Verizon analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$55.99

0.97 (1.76%)

SFTBF

SoftBank

$62.00

1.93 (3.21%)

S

Sprint

$8.17

0.12 (1.49%)

DISH

DISH

$58.51

1.85 (3.27%)

T

AT&T

$39.35

0.72 (1.86%)

VZ

Verizon

$50.36

0.61 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

  • 24

    Jan

NUS

Nu Skin

$51.56

0.05 (0.10%)

07:32
12/07/16
12/07
07:32
12/07/16
07:32
Hot Stocks
Nu Skin announces CEO transition plan »

Nu Skin Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

CAL

Caleres

$33.80

0.28 (0.84%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Upgrade
Caleres rating change  »

Caleres upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

, CMCSA

Comcast

$68.70

0.02 (0.03%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Conference/Events
UBS to hold a conference »

44th Annual Global Media…

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

CMCSA

Comcast

$68.70

0.02 (0.03%)

AMT

American Tower

$100.85

-1.19 (-1.17%)

HSNI

HSN, Inc.

$35.90

-0.2 (-0.55%)

TGNA

TEGNA

$22.63

0.35 (1.57%)

CNSL

Consolidated Communications

LBTYA

Liberty Global

$29.91

0.36 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

TEVA

Teva

$35.03

-2.01 (-5.43%)

, COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

07:30
12/07/16
12/07
07:30
12/07/16
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TEVA

Teva

$35.03

-2.01 (-5.43%)

COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

FTK

Flotek

$13.11

-0.47 (-3.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 03

    Apr

07:30
12/07/16
12/07
07:30
12/07/16
07:30
General news
Treasury Market Outlook: bond yields are several ticks lower globally »

Treasury Market Outlook:…

CBS

CBS

$60.97

0.16 (0.26%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
CBS analyst commentary  »

CBS remains a top pick at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

P

Pandora

$13.78

0.41 (3.07%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
Pandora analyst commentary  »

Pandora Premium will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

, LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Conference/Events
Bernstein to hold a summit »

3rd Annual Consumer…

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

SAP

SAP

$82.99

-0.14 (-0.17%)

TSN

Tyson Foods

$57.39

0.12 (0.21%)

TUP

Tupperware Brands

$55.46

0.24 (0.43%)

CDXC

ChromaDex

$2.39

0.05 (2.14%)

TVIA

Tvia, Inc.

$1.25

0.1 (8.70%)

HRL

Hormel Foods

$33.31

-0.48 (-1.42%)

RCL

Royal Caribbean

$81.15

0.1 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 13

    Dec

  • 09

    Jan

RKDA

Arcadia Biosciences

, SEED

Origin Agritech

$2.50

0.02 (0.81%)

07:28
12/07/16
12/07
07:28
12/07/16
07:28
Conference/Events
UBS to hold a conference »

2016 UBS Agriculture Day…

RKDA

Arcadia Biosciences

SEED

Origin Agritech

$2.50

0.02 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

OSIS

OSI Systems

$76.45

0.51 (0.67%)

, ZIXI

ZixCorp

$4.45

0.03 (0.68%)

07:27
12/07/16
12/07
07:27
12/07/16
07:27
Conference/Events
Imperial Capital to hold a conference »

2016 Security Investor…

OSIS

OSI Systems

$76.45

0.51 (0.67%)

ZIXI

ZixCorp

$4.45

0.03 (0.68%)

APDN

Applied DNA Sciences

$2.25

0.05 (2.27%)

ASCMA

Ascent Capital

$18.00

-0.19 (-1.04%)

BCO

Brink's

$39.95

0.9 (2.30%)

CTRL

Control4

$11.20

0.01 (0.09%)

NSSC

NAPCO Security

$8.15

0.15 (1.88%)

VRNT

Verint

$38.20

0.15 (0.39%)

INVE

Identiv

$2.58

0.11 (4.45%)

QLYS

Qualys

$32.25

-0.25 (-0.77%)

TASR

TASER

$28.19

0.11 (0.39%)

PCTI

PCTEL

$5.06

0.09 (1.81%)

RDWR

Radware

$13.64

0.07 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

CGEN

Compugen

$6.10

0.1 (1.67%)

07:26
12/07/16
12/07
07:26
12/07/16
07:26
Hot Stocks
Compugen discloses cancer immunotherapy program for TIGIT »

Compugen disclosed today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$14.69

1.01 (7.38%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Credit Suisse to hold a conference »

2016 Quantitative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

EW

Edwards Lifesciences

$83.22

0.73 (0.88%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ARGS

Argos Therapeutics

$4.75

0.05 (1.06%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Argos Therapeutics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TCRD

THL Credit

$10.32

-0.02 (-0.19%)

, FSIC

FS Investment

$10.05

-0.05 (-0.50%)

07:24
12/07/16
12/07
07:24
12/07/16
07:24
Conference/Events
Wells Fargo to hold a forum »

2016 Middle Market…

TCRD

THL Credit

$10.32

-0.02 (-0.19%)

FSIC

FS Investment

$10.05

-0.05 (-0.50%)

BKCC

BlackRock Capital Investment

$7.41

0.08 (1.09%)

NMFC

New Mountain Finance

$14.20

-0.05 (-0.35%)

SLRC

Solar Capital

$20.67

0.14 (0.68%)

TCPC

TCP Capital

$16.95

-0.03 (-0.18%)

MAIN

Main Street

$36.37

-0.04 (-0.11%)

TSLX

TPG Specialty Lending

$18.49

0.12 (0.65%)

HTGC

Hercules Capital

$13.62

-0.12 (-0.87%)

KKR

KKR

$15.87

0.2 (1.28%)

TROW

T. Rowe Price

$76.09

0.51 (0.67%)

APO

Apollo Global

$19.28

0.03 (0.16%)

BX

Blackstone

$26.55

0.15 (0.57%)

GS

Goldman Sachs

$231.38

2.83 (1.24%)

WFC

Wells Fargo

$55.55

1.2 (2.21%)

ARCC

Ares Capital

$16.31

0.17 (1.05%)

MCC

Medley Capital

$7.63

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 15

    Dec

WDC

Western Digital

$63.85

1.76 (2.83%)

07:24
12/07/16
12/07
07:24
12/07/16
07:24
Recommendations
Western Digital analyst commentary  »

Brean Capital ups Western…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LW

Lamb Weston

$33.82

0.17 (0.51%)

07:23
12/07/16
12/07
07:23
12/07/16
07:23
Recommendations
Lamb Weston analyst commentary  »

Lamb Weston should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FI

Frank's International

$12.51

-0.09 (-0.71%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Syndicate
Breaking Syndicate news story on Frank's International »

Frank's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMO

Bank of Montreal

$69.33

1.85 (2.74%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Upgrade
Bank of Montreal rating change  »

Bank of Montreal upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$57.92

0.64 (1.12%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Periodicals
Citi says operations ran properly in sterling 'flash crash,' Reuters reports »

Citi said its trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 26

    Jan

EVHC

Envision Healthcare

$71.70

-0.05 (-0.07%)

07:20
12/07/16
12/07
07:20
12/07/16
07:20
Upgrade
Envision Healthcare rating change  »

Envision Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

07:20
12/07/16
12/07
07:20
12/07/16
07:20
General news
FX Update: The dollar settled at near net unchanged levels »

FX Update: The dollar…

BMY

Bristol-Myers

$56.03

0.48 (0.86%)

, ARAY

Accuray

$5.05

0.1 (2.02%)

07:18
12/07/16
12/07
07:18
12/07/16
07:18
Conference/Events
Citigroup to hold a conference »

2016 Global Healthcare…

BMY

Bristol-Myers

$56.03

0.48 (0.86%)

ARAY

Accuray

$5.05

0.1 (2.02%)

AERI

Aerie Pharmaceuticals

$40.40

0.1 (0.25%)

AMGN

Amgen

$145.11

-0.18 (-0.12%)

ALXN

Alexion

$124.17

-0.76 (-0.61%)

MRK

Merck

$60.28

0.03 (0.05%)

MD

MEDNAX

$67.05

1.13 (1.71%)

PKI

PerkinElmer

$52.10

0.95 (1.86%)

CYH

Community Health

$5.73

0.22 (3.99%)

TSRO

TESARO

$139.87

0.31 (0.22%)

AGN

Allergan

$190.94

-0.24 (-0.13%)

ISRG

Intuitive Surgical

$621.59

-15.36 (-2.41%)

VNRX

VolitionRx

$4.31

-0.08 (-1.82%)

OPK

OPKO Health

$11.33

0.54 (5.00%)

NVO

Novo Nordisk

$35.26

0.84 (2.44%)

HRC

Hill-Rom

$55.02

0.95 (1.76%)

CYTK

Cytokinetics

$11.30

0.05 (0.44%)

ACRS

Aclaris Therapeutics

$30.55

0.4 (1.33%)

UHS

Universal Health

$126.37

1.59 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 11

    Jan

  • 08

    Mar

  • 19

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.